STEX · Streamex Corp.
$0.70
-0.03 (-3.55%)
At close · Jul 29
Market Cap
$76.10M
Shares
104.27M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$40K
+122.2%
FY2024
Net Income
-$462.78M
-4379.9%
FY2025
Gross Margin
100%
+19.9pp
FY2023
Operating Margin
-32155%
+126245pp
FY2024
Diluted EPS
-$9.65
-1186.7%
FY2025
Operating Cash Flow
-$10.44M
-119.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | $40K | $18K | $286K | $441K | $0 | — | — | — | — | — | — | — | |
| — | -$1.59M | -$11K | $9000 | $3000 | $2000 | $45K | $133K | $10.9K | $75 | $1 | -$1298 | -$11.03K | -$70.06K | |
| — | — | — | — | $57K | $199K | $0 | — | — | — | — | — | — | — | |
| — | — | — | $18K | $229K | $242K | $0 | — | — | — | — | — | — | — | |
| — | — | — | 100% | 80.07% | 54.88% | — | — | — | — | — | — | — | — | |
| — | $31K | $832K | $5.09M | $5.82M | $5.6M | $18.14M | $9.74M | $4.37M | $4.76M | $2.65M | $1.51M | $1.51M | $992.21K | |
| $98.83M | $67.53M | $11.63M | $23.08M | $21.38M | $27.85M | $40.95M | $24.81M | $12.88M | $8.14M | $8.5M | $10.53M | $7.3M | $5.23M | |
| $4.98M | $3.5M | $16K | — | — | — | — | — | — | — | — | — | — | — | |
| $5.01M | $3.53M | $188K | $361K | $293K | $198K | $94K | $54K | $12.4K | — | — | — | — | — | |
| $103.86M | $71.09M | $12.9M | $28.53M | $27.49M | $33.65M | $59.18M | $34.6M | $17.26M | $12.91M | $11.16M | $12.04M | $7.87M | $6.24M | |
| -$103.86M | -$71.09M | -$12.86M | -$28.51M | -$27.27M | -$33.41M | -$59.18M | -$34.6M | -$17.26M | -$12.91M | -$11.16M | -$12.04M | -$7.87M | -$6.24M | |
| — | — | -32155% | -158400% | -9533.22% | -7576.19% | — | — | — | — | — | — | — | — | |
| -$98.85M | -$67.56M | -$12.67M | -$28.15M | -$26.97M | -$33.21M | -$59.09M | -$34.55M | -$17.25M | — | — | — | — | — | |
| — | $1.6M | — | — | — | — | — | — | — | — | — | — | — | — | |
| $5479 | — | — | — | — | — | $44.34K | — | — | — | — | — | — | — | |
| -$404.62M | -$392.92M | $2.52M | -$187K | — | — | — | — | — | — | -$422.91K | $2.58M | -$604.8K | — | |
| -$508.47M | -$464.01M | -$10.34M | -$28.69M | -$27.26M | -$32.86M | -$59.14M | -$34.47M | -$17.25M | -$12.7M | -$11.59M | -$9.46M | -$8.47M | -$9.8M | |
| — | -$1.25M | $0 | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$506.66M | -$462.78M | -$10.33M | -$29.04M | -$27.05M | -$31.92M | -$52.22M | -$34.06M | -$18.14M | -$12.7M | -$11.59M | -$9.46M | -$8.47M | -$9.8M | |
| — | — | -25825% | -161338.89% | -9458.74% | -7237.41% | — | — | — | — | — | — | — | — | |
| — | $15K | -$9000 | $351K | -$210K | -$939K | -$6.92M | -$415.85K | $0 | — | — | — | — | — | |
| -$506.67M | -$462.79M | -$10.51M | -$29.05M | -$27.27M | -$31.93M | -$52.23M | -$34.08M | -$18.14M | -$12.82M | -$11.7M | -$9.81M | -$8.77M | -$10.1M | |
| -$507.76M | -$461.96M | -$10.33M | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$9.65 | -$0.75 | -$3.95 | -$6.33 | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$9.65 | -$0.75 | -$3.95 | -$6.33 | — | — | — | — | — | — | — | — | — |
| shares | — | 47.97M | 14.04M | 7.35M | 4.31M | — | 2.79M | 2.07M | 1.45M | 1.02M | 1.95M | 1.41M | 965.03K | 818.76K |
| shares | — | 47.97M | 14.04M | 7.35M | 4.31M | — | 2.79M | 2.07M | 1.45M | 1.02M | 1.95M | 1.41M | 965.03K | 818.76K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 4.40×
Peer medians compare against the 19 similar-size Capital Markets companies (of 59 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Corporate | $40,000 | — | $286,000 | $441,000 | $0 |
| NeuroClear Technologies Inc NeuroClear | — | — | — | $0 | $0 |
| ViralClear | — | — | — | $0 | $0 |
| ViralClear Pharmaceuticals Inc | — | $18,000 | — | — | — |
By Product & Service (USD)
| Component | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Service | $18,000 | $32,000 | $27,000 | $0 |
| Product | — | $254,000 | $414,000 | $0 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| ViralClear Pharmaceuticals Inc | $1,498,000 | -$672,000 | — |
| Bio Sig AI Sciences Inc | -$745,000 | -$3,000 | — |
| Corporate | -$29,265,000 | -$26,590,000 | -$29,774,000 |
| NeuroClear Technologies Inc NeuroClear | — | — | -$7,000 |
| ViralClear | — | — | -$3,630,000 |
Operating Margin by Segment (%)
| Component | FY2023 | FY2022 | FY2021 |
|---|---|---|---|
| Corporate | — | -9297.2% | -6751.5% |
| ViralClear Pharmaceuticals Inc | 8322.2% | — | — |